Histone deacetylases

Cat.No. Product Name Feedback Added

S2244

AR-42 (HDAC-42)

Jun 2011
AR-42 is a novel HDAC inhibitor with an IC50 of 0.61 μM for acute lymphoblastic leukemia (697) cell lines.
S1085

Belinostat (PXD101)

Jul 2009
Belinostat also known as PXD101 is a HDAC inhibitor with IC50 of 27 nM.
S1194

CUDC-101

May 2010
CUDC-101 is a potent multitargeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.
S1422

Droxinostat

Jul 2010
Droxinostat is a selective inhibitor of HDAC3, HDAC6, and HDAC8 (IC50 at 16.9 ,2.47 and 1.46 μM, respectively).
S2170

ITF2357 (Givinostat)

Jan 2011
ITF2357 (Givinostat) is a noverl HDAC inhibitor with IC50 of 10, 7.5 and 16 nM for maize HDAC preparations HD2, HD-1B and HD-1A, respectively.
S1096

JNJ-26481585

Aug 2009
JNJ-26481585 is an orally bioavailable, second-generation, hydroxamic acid-based HDAC inhibitor with an IC50 of 2.43 nM for 5T33MMvt cells.
S1095

LAQ824 (NVP-LAQ824)

Aug 2009
LAQ824 (NVP-LAQ824) is an HDAC inhibitor with an IC50 of 0.032 μM.
S1030

LBH589 (Panobinostat)

Apr 2009
LBH589 (Panobinostat) is a HDAC inhibitor, IC50 for inhibition of proliferation in MOLT-4 cells is approximately 5 μM and for Reh cells is approximately 20 μM.
S1484

MC1568

Sep 2010
MC1568 is a potent selective class II (IIa) histone deacetylas (HDAC II) inhibitor (IC50 of a maize deacetylase HD2 at 22.0 µM).
S1122

MGCD0103 (Mocetinostat)

Oct 2009
MGCD0103 (Mocetinostat) is a potent HDAC inhibitor with IC50 of 0.15, 0.29 and 1.66 μM for HDAC 1, HDAC 2 and HDAC 3, respectively.
S1053

MS-275 (Entinostat)

Apr 2009
MS-275 (Entinostat) is a potent HDAC inhibitor with IC50 of 0.3 and 8µM for HDAC1 and HDAC3, respectively.
S1090

PCI-24781

Jul 2009
PCI-24781 (CRA-024781) is an HDAC inhibitor with Ki of 7 μM.
S1515

SB939

Sep 2010
SB939 is a novel potent and orally active histone deacetylase inhibitor with an IC50 of 52 nM for HDAC1 and a GI50 of 0.56 µM for Colo205.
S1045

Trichostatin A (TSA)

Apr 2009
Inhibitor of HDAC, HDAC inhibitory activity of TSA was similar in all cell lines with mean ± SD IC50 of 2.4 ± 0.5 nm (range, 1.5–2.9 nm)
S2627

Tubastatin A hydrochloride

Aug 2011
Tubastatin A hydrochloride is a potent selective HDAC6 inhibitor with an IC50 of 15 nM.
S1168

Valproate

Mar 2010
Valproate is a histone deacetylase inhibitor with an IC50 of 0.4 mM and exhibits anticancer, anti-inflammatory and neuroprotective effects.
S1047

Vorinostat (SAHA)

Apr 2009
Vorinostat also known as SAHA, Zolinza, MK-0683 is an HDAC inhibitor. Vorinostat CAS No 149647-78-9 with purity >99% & solubility DMSO is available.
Buy Now / Print Quote

Find Multiple Products by Catalog Number

Continue
Customer's Feedback
Arnaud AUTRET, Trinity College
"I would like to confirm you that everything is perfectly fine with ABT and Obatoclax we got from your company. We confirmed their activity in vitro. We notably observed their impact in an apoptotic model and results are similar to those which have been published."

Dongfeng Chen, The Rausing Lab
"Your product U0126(Cat.NO S1102) works well in our experiments. I hope I can get more excellent products from your company in future."

Dr. Alexandra Segref, CECAD Cologne,Germay
"I am very satisfied with your product and costumer service. Bortezomib works very well in our assay, it is comparably cheaper than other inhibitors that we tested is more reliable for our assays. We see a great effect by using 10nM concentration."

R.B. Cambridge
"I have used the chemical that I bought from you(Selleck,PTC-124) and it worked well.So we will eventually be ordering more."

Zhenghe John Wang Assistant Professor, Case Western Reserve University
"We have purchased LBH-589, Saha and MS-275 from you and they all worked well."

Jenny Sun
"We used the LBH-589 in our experiments. The compound is easy to use with excellent reproducibility."

Yu Wang, Harvard University
"The GDC0449 compound worked very well. The results in my hands are equally good as what's been published. Thanks for this great resource for our research."

Philip Seeman, Toronto University
"Your LY404039 compound was well synthesized, its complicated stereochemical structure confirmed by NMR spectroscopy, and was biologically excellent in acting on brain dopamine receptors."

Dung-Fang Lee
"Based on our preliminary data, I found MLN8237 and VX-680 have good effects in inhibiting Aurka-maintaining ESC self-renewal in mouse ES cells."

Latest Catalog
May 2010
Selleck
Latest
Catalog

Selleck Chemicals Catalog
| Inhibitor | Antibody | siRNA | Protein | Peptide | Cell Signal | © Copyright 2010 Selleck. All Rights Reserved.